We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Evgen Pharma Plc | LSE:EVG | London | Ordinary Share | GB00BSVYN304 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.80 | 0.75 | 0.85 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 422k | -4.04M | -0.0147 | -0.54 | 2.2M |
TIDMEVG
RNS Number : 5295B
Evgen Pharma PLC
10 January 2018
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------------------------------------------- 1. Identity of the issuer or Evgen Pharma PLC the underlying issuer of existing shares to which voting rights are attached: (ii) ----------------------------------------------------------- ------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): -------------------------------------------------------------------------------------- An acquisition or disposal of voting rights X ------------------------------------------------------------ ------------------------ An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------ ------------------------ An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------ ------------------------ An event changing the breakdown of voting rights ------------------------------------------------------------ ------------------------ Other (please specify): ---------------------------------------------------------- ------------------------ 3. Full name of person(s) Seneca Partners Limited subject to the notification obligation: (iii) ----------------------------------------------------------- ------------------------- 4. Full name of shareholder(s) Share Nominees Limited (if different from 3.):(iv) WCS Nominees Limited ----------------------------------------------------------- ------------------------- 5. Date of the transaction 2 January 2018 and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------- ------------------------- 6. Date on which issuer 10 January 2018 notified: ----------------------------------------------------------- ------------------------- 7. Threshold(s) that is/are crossed or reached: (vi, vii) 5% ----------------------------------------------------------- ------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- -------------------------------- --------------------------------------------------------------------- Number Number Number Number of voting % of voting of of of shares rights rights (x) Shares Voting Rights ------------- --------------- --------------- -------------- -------------------------- ------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- ----------- ----------- -------------- ------------ ------------ ------------ ----------- GB00BSVYN304 3,536,022 3,536,022 6,872,726 6,872,726 7.37% ------------- --------------- --------------- -------------- ------------ ------------ ------------ ----------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ----------------- ------------- ------------------------------- ---------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) --------------- ------------- ------------- ---------------- ---------------------------- ----------------------- Nominal Delta --------------- ------------- ------------- ---------------- ---------------------------- ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ------------------------------------------------- ------------------------------------------------------------------- 6,872,726 7.37% ------------------------------------------------- ------------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) --------------------------------------------------------------------------------------- Proxy Voting: --------------------------------------------------------------------------------------- 10. Name of the proxy holder: ------------------------------------------------------------- ------------------------ 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- ------------------------ 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- ------------------------ 13. Additional information: ------------------------------------------------------------- ------------------------ 14. Contact name: Seneca Partners Limited ------------------------------------------------------------- ------------------------ 15. Contact telephone number: 01942 271 746 ------------------------------------------------------------- ------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLBLGDBLDBBGIG
(END) Dow Jones Newswires
January 10, 2018 11:31 ET (16:31 GMT)
1 Year Evgen Pharma Chart |
1 Month Evgen Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions